Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nutrient sensors and their crosstalk. | Exp Mol Med | 2023 | 37258576 | PubTator, text mining | PubMed |
| Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies. | Cancer Immunol Res | 2023 | 37257169 | PubTator, text mining | PubMed |
| From bench to bedside: the history and progress of CAR T cell therapy. | Front Immunol | 2023 | 37256141 | PubTator, text mining | PubMed |
| Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy. | Front Immunol | 2023 | 37251405 | PubTator, text mining | PubMed |
| Universal chimeric Fcγ receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy. | Acta Pharm Sin B | 2023 | 37250170 | PubTator, text mining | PubMed |
| Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies. | Viruses | 2023 | 37243212 | PubTator, text mining | PubMed |
| Engineering Adenoviral Vectors with Improved GBM Selectivity. | Viruses | 2023 | 37243172 | PubTator, text mining | PubMed |
| Brain Calcifications: Genetic, Molecular, and Clinical Aspects. | Int J Mol Sci | 2023 | 37240341 | PubTator, text mining | PubMed |
| The Interplay between T Cells and Cancer: The Basis of Immunotherapy. | Genes (Basel) | 2023 | 37239368 | PubTator, text mining | PubMed |
| The Rhodanese PspE Converts Thiosulfate to Cellular Sulfane Sulfur in Escherichia coli. | Antioxidants (Basel) | 2023 | 37237993 | PubTator, text mining | PubMed |
| A Screening Approach to Assess the Impact of Various Commercial Sources of Crude Marine λ-Carrageenan on the Production of Oligosaccharides with Anti-heparanase and Anti-migratory Activities. | Mar Drugs | 2023 | 37233489 | PubTator, text mining | PubMed |
| Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications. | Curr Oncol | 2023 | 37232836 | PubTator, text mining | PubMed |
| Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment. | Curr Oncol | 2023 | 37232806 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured via electroporation or lentiviral transfection. | Front Immunol | 2023 | 37228617 | PubTator, text mining | PubMed |
| NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | 37228595 | PubTator, text mining | PubMed |
| Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape. | Transl Oncol | 2023 | 37224766 | PubTator, text mining | PubMed |
| Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor. | Mol Ther Oncolytics | 2023 | 37223115 | PubTator, text mining | PubMed |
| Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances. | Front Immunol | 2023 | 37215124 | PubTator, text mining | PubMed |
| Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies. | Front Immunol | 2023 | 37207215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=30